Abstract:To determine the specific epitopes on SARS-CoV nucleocapsid(N) protein,the cross-reactivities among three human coronavirus N proteins were analyzed systematically.The vaccinia recombinants were constructed to express N proteins of SARS-CoV,HCoV-OC43 and HCoV-229E.The polyclonal antibodies against the expressed N proteins were prepared with the correlated vaccinia recombinants.The indirect immunofluorescence was used to detect both the expression of N proteins in vaccinia recombinants and the cross-reactivity with antisera from three HCoVs(SARS-CoV,HCoV-OC43 and HCoV-229E) and SARS convalescent patient.The cross-or specificreactive epitopes on N proteins of three HCoVs above were further analyzed by Western blot with the E.coli expressed 39 peptides overlapping the whole N protein of SARS-CoV and also with the 4 antisera above.Immunofluorescence indicated the well expression of N proteins of SARS-CoV,HCoV-OC43 and HCoV-229E in vaccinia recombinant infected-HeLa cells and the clear antigenic cross-reactivity among the three N proteins.Four dominant antigenic epitopes on nucleocapsid protein of SARS-CoV were identified by Western blot,which were located at the amino acid positions of 30-60aa,170-184aa,301-320aa and 360-422aa.The epitopes which were cross-reactive between SARS-CoV and HCoV-OC43 were at 30-60aa,90-120aa,204-214aa and 320-360aa.The epitopes which were cross-reactive between SARS-CoV and HCoV-229E were at 30-60aa,150-160aa and 301-360aa.Importantly,we found that recombinant peptides N155b(60-214aa) and N185(30-214aa) containing the specific epitopes for SARS-CoV N protein were only reactive with the sera from SARS convalescent patient and mouse antiserum immunized with inactivated SARS-CoV,but not reactive with the goat anti-serum prepared with inactivated HCoV-OC43 or HCoV-229E.The results above provided very useful information for the development of specific diagnostic reagent using the recombinant SARS-CoV N protein.

Isolation and Identification of an Scfv Antibody Against Nucleocapsid Protein of SARS-CoV.

Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library

Recombinant Scfv Antibodies Against E Protein and N Protein of Severe Acute Respiratory Syndrome Virus

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities.

A human neutralizing antibody against a conforma- tional epitope shared by oligomeric SARS S1 protein

Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patients

Preparation of Specific Monoclonal Antibody Against Nucleocapsid Protein of SARS Coronavirus

A human SARS-CoV neutralizing antibody against epitope on S2 protein.

Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.

Identification of Human Single-Domain Antibodies Against SARS-CoV-2.

Cloning, Expression, Purification of a Fusion Protein of SARS-CoV Nucleocapsid and Spike Protein Fragments and Its Immunological Characteristics

The preparation and primary application of mAbs against nucleocapsid protein of severe fever with thrombocytopenia syndrome virus

Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus

Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS.

Production of an Anti-Severe Acute Respiratory Syndrome (SARS) Coronavirus Human Monoclonal Antibody Fab Fragment by Using a Combinatorial Immunoglobulin Gene Library Derived from Patients Who Recovered from SARS.

Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus Infection.

The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity.

Identification of Epitopes on SARS-CoV Nucleocapsid Protein That Induce the Cross-or Specific-Reactivity among SARS-CoV,HCoV-OC43 and HCoV-229E

Development of Human Single-Chain Antibodies Against Sars-Associated Coronavirus

Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips

High-specificity targets in SARS-CoV-2 N protein for serological detection and distinction from SARS-CoV